Skip to content
Screener

Geron GERN Operating Cash Flow

Operating Cash Flow at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$3.39B-13.4%
Incyte logo
IncyteINCY
$507.66M+1,035%
Immunome logo
ImmunomeIMNM
-$58.64M-10.5%
Exelixis logo
ExelixisEXEL
$307.74M+528%
CTO
Citius Oncology, Inc.CTOR
-$3.83M-179%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$408.2M-5.0%

Other financials

Income statement

See full
Revenue$57.5M+17.2%
Operating income-$12.5M-0.3%
Net income-$16.7M-1.9%
EPS (diluted)-$0.020.0%

Balance sheet

See full
Cash & equivalents$64.5M-18.9%
Total debt$134.1M-0.3%
Total equity$218.6M-15.8%
Total assets$519.0M-6.5%

Cash flow

See full
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$1.01B+13.8%
Enterprise value$1.08B+14.5%
P/S4.9×-180×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-28.3%-2.3pp
Debt / equity0.6×+0.1×
Current ratio6.9×-1.0×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Geron’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:41 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000886744-26-000037
Line itemSIX MONTHS ENDEDJUNE 30, 2026SIX MONTHS ENDEDJUNE 30, 2025
Accrued liabilities(20,624)(9,256)
Payments on royalty agreement(7,733)(6,705)
Operating lease liabilities(432)(388)
Net cash used in operating activities(78,733)(75,394)
Cash flows from investing activities:
Purchases of property and equipment(475)(138)
Purchases of marketable securities(123,423)(123,173)
Proceeds from maturities and sales of marketable securities184,049196,065

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is Geron's operating cash flow?
Geron (GERN) reported operating cash flow of -$15.83M in Q2 2026.
How has Geron's operating cash flow changed year-over-year?
Geron's operating cash flow increased by 42.3% year-over-year, from -$27.42M to -$15.83M.
What is the long-term trend for Geron's operating cash flow?
Over 4 years (2021 to 2025), Geron's operating cash flow has grown at a 3.8% compound annual growth rate (CAGR), from -$95.56M to -$111.04M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Geron's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude